Osteoporosis drug may benefit heart health
(Wiley) The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cardiology | Cardiovascular | Heart | Heart Attack | International Medicine & Public Health | Orthopaedics | Osteoporosis | Stroke | Study